Minori Shimura

1.1k total citations
33 papers, 907 citations indexed

About

Minori Shimura is a scholar working on Hematology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minori Shimura has authored 33 papers receiving a total of 907 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 9 papers in Genetics and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minori Shimura's work include Blood Coagulation and Thrombosis Mechanisms (23 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (8 papers). Minori Shimura is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (23 papers), Hemophilia Treatment and Research (10 papers) and Blood properties and coagulation (8 papers). Minori Shimura collaborates with scholars based in Japan, China and India. Minori Shimura's co-authors include Hiroshi Shiku, Hideo Wada, Yoshihiro Wakita, Tutomu Nakase, Yoshitaka Mori, T Nakase, Takahiro Nakasaki, Hiroshi Wada, Katsumi Deguchi and Masakatsu Nishikawa and has published in prestigious journals such as Thrombosis and Haemostasis, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids and American Journal of Hematology.

In The Last Decade

Minori Shimura

32 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minori Shimura Japan 18 547 307 278 170 152 33 907
J Kienast Germany 10 475 0.9× 223 0.7× 375 1.3× 200 1.2× 164 1.1× 22 1.0k
Toshihiro Kaneko Japan 18 506 0.9× 240 0.8× 195 0.7× 122 0.7× 158 1.0× 33 926
Tsuyoshi Hatada Japan 18 231 0.4× 245 0.8× 323 1.2× 117 0.7× 119 0.8× 29 1.0k
Philip M. Blatt United States 17 714 1.3× 167 0.5× 153 0.6× 252 1.5× 127 0.8× 38 1.3k
Shin Koga Japan 9 249 0.5× 148 0.5× 235 0.8× 93 0.5× 96 0.6× 18 612
Colin Downey United Kingdom 13 285 0.5× 126 0.4× 235 0.8× 85 0.5× 135 0.9× 22 868
Susan Nahirniak Canada 14 357 0.7× 231 0.8× 169 0.6× 321 1.9× 56 0.4× 45 1.1k
C. Rintelen Austria 18 478 0.9× 212 0.7× 44 0.2× 138 0.8× 143 0.9× 27 807
William McGehee United States 16 414 0.8× 180 0.6× 97 0.3× 173 1.0× 167 1.1× 24 973
P. Cooper United Kingdom 18 723 1.3× 355 1.2× 65 0.2× 198 1.2× 97 0.6× 49 1.1k

Countries citing papers authored by Minori Shimura

Since Specialization
Citations

This map shows the geographic impact of Minori Shimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minori Shimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minori Shimura more than expected).

Fields of papers citing papers by Minori Shimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minori Shimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minori Shimura. The network helps show where Minori Shimura may publish in the future.

Co-authorship network of co-authors of Minori Shimura

This figure shows the co-authorship network connecting the top 25 collaborators of Minori Shimura. A scholar is included among the top collaborators of Minori Shimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minori Shimura. Minori Shimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimura, Minori, Makoto Hosono, Yasusada Miura, et al.. (2005). Isohumulones modulate blood lipid status through the activation of PPARα. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1736(1). 51–60. 35 indexed citations
2.
Wada, Hideo, Esteban C. Gabazza, Takahiro Nakasaki, et al.. (2000). Diagnosis of Disseminated Intravascular Coagulation by Hemostatic Molecular Markers. Seminars in Thrombosis and Hemostasis. Volume 26(Number 01). 17–22. 21 indexed citations
3.
Wada, Hideo, et al.. (2000). Increased Hemostatic Molecular Markers in Patients Undergoing Anticoagulant Therapy. Seminars in Thrombosis and Hemostasis. Volume 26(Number 01). 113–118. 2 indexed citations
4.
Shimura, Minori, Hideo Wada, Masakatsu Nishikawa, et al.. (1999). Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. American Journal of Hematology. 60(2). 94–98. 17 indexed citations
5.
Wada, Hideo, Yoshitaka Mori, Minori Shimura, et al.. (1999). Hemostatic markers in Japanese patients undergoing anticoagulant therapy under thrombo-test monitoring. Blood Coagulation & Fibrinolysis. 10(7). 429–434. 5 indexed citations
6.
Wada, Hideo, Yoshitaka Mori, Minori Shimura, et al.. (1999). Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation. American Journal of Hematology. 61(1). 21–25. 11 indexed citations
7.
Wada, Hideo, Yoshitaka Mori, Minori Shimura, et al.. (1998). Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. American Journal of Hematology. 58(3). 189–194. 3 indexed citations
8.
Wada, Hiroshi, Akiko Inoue, Ichiro Tsuji, et al.. (1998). Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis. 9(6). 491–498. 26 indexed citations
9.
Wada, Hideo, Minori Shimura, Takahiro Nakasaki, et al.. (1998). Increased thrombopoietin levels in idiopathic thrombocytopenic purpura patients with a poor response to steroid therapy. Blood Coagulation & Fibrinolysis. 9(4). 315–322. 12 indexed citations
10.
Wada, Hideo, Yoshitaka Mori, Minori Shimura, et al.. (1998). Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries. American Journal of Hematology. 58(3). 189–194. 59 indexed citations
11.
Sumida, Yasuhiro, Hideo Wada, Masashi Fujii, et al.. (1997). Increased soluble fibrin monomer and soluble thrombomodulin levels in non-insulin-dependent diabetes mellitus. Blood Coagulation & Fibrinolysis. 8(5). 303–307. 13 indexed citations
12.
Wada, Hideo, Minori Shimura, Takahiro Nakasaki, et al.. (1997). Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis. 8(6). 345–349. 29 indexed citations
13.
Wada, Hideo, Atsushi Yamada, Minori Shimura, et al.. (1997). Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. American Journal of Hematology. 55(4). 183–187. 39 indexed citations
14.
Wada, Hideo, Atsushi Yamada, Minori Shimura, et al.. (1997). Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. American Journal of Hematology. 55(4). 183–187. 1 indexed citations
15.
Shimura, Minori, et al.. (1997). Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. American Journal of Hematology. 55(4). 169–174. 66 indexed citations
16.
Wada, Hideo, Yoshihiro Wakita, T Nakase, et al.. (1996). Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. American Journal of Hematology. 51(4). 255–260. 67 indexed citations
17.
Yamada, Atsushi, et al.. (1996). Plasma levels of activated FVII in various diseases. Blood Coagulation & Fibrinolysis. 7(8). 794–798. 9 indexed citations
18.
Shimura, Minori, et al.. (1996). Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. American Journal of Hematology. 52(3). 165–170. 24 indexed citations
19.
Nakase, T, Hideo Wada, Kouzou Minamikawa, et al.. (1994). Increased activated protein C-protein C inhibitor complex level in patients positive for lupus anticoagulant. Blood Coagulation & Fibrinolysis. 5(2). 173–178. 26 indexed citations
20.
Deguchi, Akira, Katsumi Deguchi, Minori Shimura, et al.. (1993). Spa Bathing Activates Fibrinolysis in Patients with Cerebral Infarction.. Internal Medicine. 32(8). 619–622. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Kienast Breakdown of academic impact, for papers by Toshihiro Kaneko Breakdown of academic impact, for papers by Tsuyoshi Hatada Breakdown of academic impact, for papers by Philip M. Blatt Breakdown of academic impact, for papers by Shin Koga Breakdown of academic impact, for papers by Colin Downey Breakdown of academic impact, for papers by Susan Nahirniak Breakdown of academic impact, for papers by C. Rintelen Breakdown of academic impact, for papers by William McGehee Breakdown of academic impact, for papers by P. Cooper
Rankless by CCL
2026